Derebe Dagninet, Wubetu Muluken, Alamirew Amare
Department of Pharmacy, College of Medicine and Health Sciences, Bahir Dar University, Bahir Dar, Ethiopia.
Department of Pharmacy, College of Health Sciences, Debre Markos University, Debre Markos, Ethiopia.
Clin Pharmacol. 2021 Jul 16;13:157-167. doi: 10.2147/CPAA.S313847. eCollection 2021.
Due to resistance of parasites, costs, and safety issues with currently available drugs, there is a need to discover new antimalarials. Medicinal plants are one of the most important sources of new drugs. The purpose of this study was to evaluate the antimalarial activity of a methanolic root extract of in Swiss albino mice infected with .
Four-day suppressive, curative, and prophylactic tests were performed on mice infected with to evaluate the antimalarial activity of a methanolic root extract of the plant. Parasitemia suppression, survival time, body-weight change, rectal temperature change, and packed-cell volume were used to evaluate the activity of the extract. Data were analyzed using one-way ANOVA followed by Tukey's post hoc test for comparisons between and within groups, with <0.05 considered statistically significant.
The . root extract showed significant (<0.01) parasitemia-suppressive activities in all models compared to the negative control. The extract increased mean survival time and prevented weight loss, reduction in temperature, and anemia significantly in all tested doses in 4-day suppressive and curative tests.
Based on these findings, root has promising antimalarial activity and can considered a potential source to develop new agents.
由于寄生虫的耐药性、现有药物的成本和安全性问题,需要发现新的抗疟药物。药用植物是新药的最重要来源之一。本研究的目的是评估在感染了[具体寄生虫名称未给出]的瑞士白化小鼠中,[植物名称未给出]甲醇根提取物的抗疟活性。
对感染了[具体寄生虫名称未给出]的小鼠进行为期四天的抑制、治疗和预防试验,以评估该植物甲醇根提取物的抗疟活性。采用寄生虫血症抑制、存活时间、体重变化、直肠温度变化和红细胞压积来评估提取物的活性。数据采用单因素方差分析,随后进行Tukey事后检验以比较组间和组内差异,P<0.05被认为具有统计学意义。
与阴性对照相比,[植物名称未给出]根提取物在所有模型中均显示出显著(P<0.01)的寄生虫血症抑制活性。在为期四天的抑制和治疗试验中,该提取物在所有测试剂量下均显著增加了平均存活时间,并预防了体重减轻、体温降低和贫血。
基于这些发现,[植物名称未给出]根具有有前景的抗疟活性,可被视为开发新药物的潜在来源。